SCHEMBL9998294

SCHEMBL9998294

CC(=O)OC(OC(C)=O)/C(=C/c1cccc(Br)c1)Cc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TSHR P16473 1/20 0.41
SLC6A19 Q695T7 1/20 0.40
PLAAT5 Q96KN8 1/20 0.40
PLAAT4 Q9UL19 1/20 0.40
PTGES O14684 1/20 0.40
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
EGFR P00533 1/20 0.39
ERBB2 P04626 1/20 0.39
MCL1 Q07820 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
HSD17B3 P37058 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
BACE1 P56817 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997590 1.00 ALDH1A1 (0.42) ALDH1A1MAPTHTTNPSR1TSHR
SCHEMBL9998025 0.87 CYP3A4 (0.50) ALDH1A1TSHRAKR1C3CYP3A4CYP2C9
SCHEMBL9998023 0.87 CYP3A4 (0.50) ALDH1A1TSHRAKR1C3CYP3A4CYP2C9
SCHEMBL9997837 0.86 TSHR (0.42) ALDH1A1MAPTNPSR1TSHREGFR
SCHEMBL9997839 0.86 TSHR (0.42) ALDH1A1MAPTNPSR1TSHREGFR
SCHEMBL9997711 0.86 TSHR (0.42) ALDH1A1TSHRCYP3A4CYP2C9
SCHEMBL9997710 0.86 TSHR (0.42) ALDH1A1TSHRCYP3A4CYP2C9
SCHEMBL9997923 0.86 TSHR (0.44) ALDH1A1MAPTNPSR1TSHRPLAAT5
SCHEMBL9997926 0.86 TSHR (0.44) ALDH1A1MAPTNPSR1TSHRPLAAT5
SCHEMBL9998418 0.85 CNR2 (0.42) MAPTTSHRAKR1C3AKR1C2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 ALDH1A1 160/4885MAPT 2206/4885HTT 1667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.